Verona Pharma PLC logo

Verona Pharma PLC - ADR

NAS:VRNA (UK)   ADR
$ 16.10 -0.3 (-1.83%) 04:00 PM EST
At Loss
P/B:
5.19
Volume:
489.99K
Avg Vol (2M):
424.32K
Also Trade In:
Volume:
489.99K
At Loss
Avg Vol (2M):
424.32K

Business Description

Description
Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for the treatment of respiratory diseases with unmet medical needs. The company is currently focusing on developing its Ensifentrine product candidate, which will treat chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), and other respiratory diseases, including asthma.
Name Current Vs Industry Vs History
Cash-To-Debt 5.3
Equity-to-Asset 0.81
Debt-to-Equity 0.21
Debt-to-EBITDA -1
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 59.08
9-Day RSI 53.65
14-Day RSI 51.06
6-1 Month Momentum % 13.82
12-1 Month Momentum % -26.97

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 33.33
Quick Ratio 33.33
Cash Ratio 31.27

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -11.6
Shareholder Yield % -6.15

Financials (Next Earnings Date:2024-05-09 Est.)

VRNA's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:VRNA

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Verona Pharma PLC Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -0.72
Beta -0.25
Volatility % 57.37
14-Day RSI 51.06
14-Day ATR ($) 0.697241
20-Day SMA ($) 16.2135
12-1 Month Momentum % -26.97
52-Week Range ($) 11.83 - 23.81
Shares Outstanding (Mil) 77.45

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Verona Pharma PLC Filings

Filing Date Document Date Form
No Filing Data

Verona Pharma PLC Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Verona Pharma PLC Frequently Asked Questions

What is Verona Pharma PLC(VRNA)'s stock price today?
The current price of VRNA is $16.10. The 52 week high of VRNA is $23.81 and 52 week low is $11.83.
When is next earnings date of Verona Pharma PLC(VRNA)?
The next earnings date of Verona Pharma PLC(VRNA) is 2024-05-09 Est..
Does Verona Pharma PLC(VRNA) pay dividends? If so, how much?
Verona Pharma PLC(VRNA) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1